|
|
|
|
Vol. 58, Issue 6, 1294-1302, December 2000
B Mediates Simultaneous Induction of Inducible
Nitric-Oxide Synthase and Up-Regulation of the Cationic Amino Acid
Transporter CAT-2B in Rat Alveolar Macrophages
Institute of Pharmacology and Toxicology, Rheinische Friedrich Wilhelms University, Bonn, Germany
| |
Abstract |
|---|
|
|
|---|
The connection between the regulation of L-arginine
transport and nitric oxide (NO) synthesis was studied in rat alveolar macrophages. Lipopolysaccharides (LPSs) and interferon-
stimulated in the same concentration- and time-dependent manner NO
synthesis (measured by nitrite accumulation) and
L-[3H]arginine uptake. This correlated with
an increased mRNA expression for iNOS and the cationic amino acid
transporter CAT-2B (analyzed by reverse transcription-polymerase chain
reaction), with the same kinetics observed for the up-regulation of
both mRNAs. Because nuclear factor-
B (NF-
B) is essential for
induction of iNOS its role for the regulation of CAT-2B expression and
L-arginine transport was investigated. The NF-
B
inhibitors pyrrolidine dithiocarbamate and
N
-p-tosyl-L-lysine
chloromethyl ketone abrogated LPS- and interferon-
-induced increase
of nitrite accumulation and L-[3H]arginine
uptake as well as up-regulation of iNOS and CAT-2B mRNA. LPS-induced
increase in iNOS and CAT-2B mRNA was also suppressed by specific
NF-
B decoy oligodesoxynucleotides, confirming the essential role of
NF-
B for iNOS and CAT-2B expression. Dexamethasone did not affect
the initial (5 h) LPS-induced increase of iNOS and CAT-2B mRNA, but
down-regulated both mRNAs after prolonged (20 h) exposure and this was
accompanied by partial inhibition of LPS-stimulated nitrite
accumulation and L-[3H]arginine uptake. These
findings demonstrate parallel regulation of the expression of iNOS and
CAT-2B, and of NO synthesis and L-arginine uptake in rat
alveolar macrophages. NF-
B is an essential transcription factor not
only for the induction of iNOS, but also for the up-regulation of
CAT-2B. The simultaneous up-regulation of CAT-2B with iNOS is
considered as a mechanism to ensure a high substrate supply for
iNOS.
| |
Introduction |
|---|
|
|
|---|
Macrophages
(M
) play an important role in host defense and immunity, and
synthesis and release of nitric oxide (NO) are important elements of
their machinery to fulfil these functions. Thus, NO is part of the
effector mechanisms in the nonspecific defense (Moncada et al., 1991
),
but may also act as a signaling molecule to control inflammatory
reactions (Brunn et al., 1997
; Thomassen et al., 1997
). Three
isoenzymes of NO synthase (NOS) have been identified (Moncada et al.,
1991
; Förstermann and Kleinert, 1995
) of which the inducible form
(iNOS, also named NOS II) is responsible for NO production in M
,
including alveolar M
(AM
) (Xie et al., 1992
; Hey et al., 1995
).
Bacterial lipopolysaccharides (LPSs) and the cytokine interferon-
(IFN-
) are strong inducers of iNOS in M
and AM
(Sherman et
al., 1993
; Martin et al., 1994
; Hey et al., 1995
; Kim et al., 1995
).
Stimulation of NO synthesis in iNOS-expressing cells correlates usually
with corresponding changes in iNOS mRNA levels, indicating that a major
part of iNOS regulation occurs at the level of transcription
(Förstermann and Kleinert, 1995
). The promoter regions of the
mouse (Lowenstein et al., 1993
), human (Zhang et al., 1996
), and rat
(Eberhardt et al., 1996
) iNOS genes have been characterized and contain
several binding sites for transcription factors such as nuclear factor
B (NF-
B), activator protein-1, and various members of the
CCAAT/enhancer-binding protein (C/EBP), activating transcription
factor/cAMP response element binding protein (ATF/CREB), and signal
transducer and activator of transcription (STAT) family of
transcription factors. Among these transcription factor recognition
sites only the activation of a downstream NF-
B site (Xie et al.,
1994
), the enhancer function of an upstream NF-
B site (Kim et al.,
1997
), and the activation of a novel lipopolysaccharide-response
element, termed LREAA (Xie, 1997
), have been
shown to be involved in the expression of the iNOS gene in murine M
in response to LPS and/or IFN-
. Finally, several lines of evidence
indicate that NF-
B is an essential, although alone not sufficient
transcription factor for the induction of iNOS in rat and mouse M
(Sherman et al., 1993
; Xie et al., 1994
; Ding et al., 1995
; Kim et al.,
1995
; Xie, 1997
).
Once expressed, iNOS is active and the amount of NO synthesized by M
depends critically on the availability of L-arginine (Baydoun et al., 1994
; Hey et al. 1997
; Hammermann et al., 1998
). Induction of iNOS in M
and AM
is accompanied by an up-regulation of L-arginine uptake (Bogle et al., 1992
; Hammermann et
al., 1999
). Different transport systems for the cellular uptake of
L-arginine have been characterized, such as the cationic
amino acid-specific, high-affinity transport system
y+ and several broad-scope amino acid transport
systems (system y+L, b0,+,
and B0,+) (Closs, 1996
; Devés and Boyd,
1998
). System y+ plays a particular role in M
and appears to mediate essentially the LPS-stimulated
L-arginine transport (Bogle et al., 1992
; Messeri Drei
ig
et al., 2000
). At the molecular level the transport properties of
system y+ could be ascribed to a family of
cationic amino acid transporters (CATs) (Closs, 1996
; Devés and
Boyd, 1998
). In rat and mouse AM
CAT-1 and a splicing variant of the
CAT-2 gene (CAT-2B) were found to be expressed (Racké et al.,
1998
), and the LPS-induced up-regulation of L-arginine
transport was accompanied by an increased expression of CAT-2B, but not
of CAT-1 (Messeri Drei
ig et al., 2000
).
The question arose whether the concomitant induction of iNOS and
up-regulation of L-arginine transport and CAT-2B expression occurred via the same signal transduction pathway. Because NF-
B plays an essential role in the control of iNOS expression in M
, it
was tested whether this signal transduction pathway is also involved in
the up-regulation of L-arginine transport and the expression of CAT-2B in rat AM
, as a model of primary M
.
| |
Experimental Procedures |
|---|
|
|
|---|
Materials.
Amphotericin B, L-arginine HCl,
cycloheximide, deoxynucleotide mixture, dexamethasone,
Dulbecco's modified Eagle's medium/nutrient mixture Ham's
F-12, rat interferon-
, lipopolysaccharides from Escherichia
coli 0127:B8, mifepristone (RU-486), penicillin-streptomycin solution, pyrrolidine dithiocarbamate (PDTC), RedTaq DNA-polymerase, and
N
-p-tosyl-L-lysine
chloromethyl ketone (TLCK) were all purchased from Sigma
(Deisenhofen, Germany).
L-[2,3-3H]arginine HCl
(1481 GBq/mmol) was purchased from DuPont (Dreieich, Germany), fetal
calf serum from Vitromex (Vilshofen, Germany), DC Protein Assay from
Bio-Rad (Munich, Germany), Trizol reagent for RNA isolation from Life
Technologies (Karlsruhe, Germany), and avian myeloblastosis
virus reverse transcriptase from Promega (Mannheim, Germany). All
oligodesoxynucleotides for reverse transcription-polymerase chain
reaction (RT-PCR) and decoy approach were obtained from MWG Biotech
(Ebersberg, Germany).
Cell Preparation and Culture.
Sprague-Dawley rats (own
breeding) of either sex were killed by stunning followed by
exsanguination. Lung and trachea were excised en bloc and lavaged three
times by instilling 10 to 15 ml of cold PBS. Usually, for one
preparation of AM
, lavage fluids from several lungs were pooled and
centrifuged at 2500 rpm for 10 min. Thereafter, cells were resuspended
in Dulbecco's modified Eagle's medium/nutrient mixture Ham's F-12
supplemented with 5% fetal calf serum, 100 U/ml penicillin, 100 µg/ml streptomycin, and 5 µg/ml amphotericin B, and plated in
12-well plates (106 AM
for uptake and NO
accumulation studies), or 4 × 106 AM
were disseminated on 35-mm culture dishes (for RT-PCR and immunoblots).
AM
were allowed to adhere for 2 h (37°C, 5%
CO2), before the medium was renewed to remove
nonadherent cells. The adherent cells consisted of more than 95% AM
according to morphological criteria (May Grünwald-Giemsa
staining). Thereafter, AM
were cultured for different time periods
in the absence or presence of test substances.
L-[3H]Arginine Uptake Studies.
AM
were cultured for 5 to 20 h in the absence or presence
of test substances. Subsequently, they were incubated at 37°C for 2 min in 0.5 ml L-[3H]arginine (37 kBq, 100 nM) containing Krebs-HEPES solution [composition 118.5 mM
NaCl, 5.57 mM KCl, 1.25 mM CaCl2, 0.6 mM
MgCl2, 0.03 mM EDTA, 0.06 mM
L-(+)-ascorbic acid, 20.0 mM HEPES (adjusted to pH 7.4 using NaOH) and 11.1 mM D-(+)-glucose]. Cells were lysed in 0.5 ml Tris/Triton (0.1%) solution followed by determination of the
cellular radioactivity (Hey et al., 1997
) and protein content using the
DC Protein Assay (Bio-Rad). The 2-min incubation period was chosen
because L-[3H]arginine (100 nM)
uptake was linear between 1 and 3 min (Racké et al., 1998
).
L-[3H]arginine uptake was expressed
either in absolute terms (picomoles per milligram of protein) or as
percentage of the uptake observed in respective controls of the
respective cell preparation.
Nitrite Assay.
As a measure of NO synthesis during the
culture period nitrite that accumulated in the culture media was
determined. To estimate the iNOS activity after the 20-h culture
period, the culture medium was removed and the AM
were incubated for
6 h in Krebs' solution containing 100 µM
L-arginine. Nitrite was quantified by a spectrophotometric assay based on the Griess reaction as described previously (Hey et al.,
1995
). Briefly, 400 µl of Griess reagent [1% sulfanilic acid, 0.1%
N-(1-naphthyl)ethylenediamine hydrochloride dissolved in
2.5% (w/v) H3PO4] was
added to 400-µl incubation medium. After 20 min of incubation at room
temperature absorbance was measured at 540 nm. The nitrite contents
given under Results were calculated from a standard curve
(NaNO2) and expressed in absolute terms (nanomoles per 106 cells).
Immunoblotting of iNOS.
Cellular proteins were extracted and
separated by SDS-polyacrylamide gel (7.5%) electrophoresis (10 µg of
protein per lane) and then transferred onto a polyvinylidene difluoride
membrane. The immobilized proteins were visualized by subsequent
incubation with a polyclonal rabbit antibody against mouse iNOS
(Calbiochem, Bad Soden, Germany). A polyclonal horseradish
peroxidase-conjugated goat anti-rabbit IgG (Bio-Rad) was used as
secondary antibody and staining was performed with the BM
chemiluminescence blotting kit (Boehringer Mannheim, Mannheim,
Germany). The "housekeeping" protein
-tubulin was detected with
a monoclonal mouse anti-human
-tubulin antibody (Cedarlane, Hornby,
Ontario, Canada), which shows cross-reactivity to rat
-tubulin and a
secondary horseradish peroxidase-conjugated goat anti-mouse IgG
(Bio-Rad). Finally, the blots were exposed to Hyperfilm ECL (Amersham
Buchler, Braunschweig, Germany).
Extraction of RNA and RT-PCR.
Total RNA was isolated from
AM
cultured for different time periods (up to 29 h) in the
absence or presence of test substances and from freshly isolated AM
using Trizol reagent. The first strand cDNA was synthesized from 2 µg
of total RNA using Oligo(dT)18 primer and avian
myeloblastosis virus reverse transcriptase under the conditions
recommended by the supplier. The cDNA products were used for subsequent
amplification by PCR. Oligonucleotide primers were constructed based on
European Molecular Biology Laboratory sequences for rat
(r)
-actin (accession number V01217; J00691), riNOS (L12562), rCAT-1
(L10151), and rCAT-2B (U53927). Primer pairs were as follows:
r
-actin (612 bp), 5'-TTCTACAATGAGCTGCGTGTGGC-3' and
5'-AGAGGTCTTTACGGATGTCAACG-3'; riNOS (525 bp),
5'-CATGAACTCCAAGAGTTTGACCAG-3' and 5'-GCCCAGGTCGATGCACAACTGG-3'; rCAT-1
(769 bp), 5'-GCTGCCTCAACACCTATGATCTGG-3' and
5'-ACGATGCCCACAGGAATGGC-3'; rCAT-2B (1050 bp),
5'-ATGGTGGCTGGGTTTGTGAAAG-3' and 5'-CAACCCATCCTCCGCCATAGC-3'. PCR
amplification was performed using RedTaq DNA polymerase and specific
primers in a programmable thermal reactor (RoboCycler; Stratagene,
Amsterdam, The Netherlands) with initial heating for 3 min at 94°C,
followed by 25 (iNOS, CAT-2B), 35 (CAT-1), or 23-25 (
-actin) cycles
of 45-s denaturation at 94°C, annealing at 56°C (30 s), extension
at 72°C (1 min), and a final extension for 10 min at 72°C. PCR
products were separated by a 1.2% agarose gel electrophoresis,
documented by a video documentation system, and quantified by the
RFLPscan software (MWG Biotech). In all PCRs a single amplification
product of the expected size was obtained.
NF-
B Decoy Approach.
Double-stranded ODNs were prepared
from the complementary single-stranded partially
phosphorothioate-bonded ODNs by melting at 95°C for 5 min followed by
a cool-down phase of 3 h at room temperature. The double-stranded
ODNs were preincubated with the cultured AM
after the 2-h adhesion
period for 4 or 24 h at a concentration of 10 µM. Thereafter, 1 µg/ml LPS was added for 5 h followed by RNA isolation and
RT-PCR. The single-stranded sequences of the NF-
B decoy ODN were as
follows (underlined letters denote phosphorothioate-bonded bases):
sense 5'-CTACTGGGACTCTCCCTTTG-3' and that of
the mutated ODN (bold letters mark mutations in the NF-
B consensus
sequence)
5'-CTACTATCTCTCTGACTTTG-3'.
Statistical Analysis. All values are means ± S.E.M. of n experiments. Statistical significance of differences was evaluated by Student's t test or paired t test when appropriate. ANOVA followed by Dunnett's t test was performed when multiple test groups were compared with one control using the computer program GraphPad InStat (GraphPad Software, San Diego, CA).
| |
Results |
|---|
|
|
|---|
LPS- and IFN-
-Evoked Up-Regulation of NO Production,
L-Arginine Uptake, and mRNA Expression.
Exposure of
AM
to LPS or IFN-
resulted in induction of iNOS mRNA (Figs. 3 and
7; Table 1) and protein (Fig. 2C), and an up-regulation of nitrite production (Figs.
1 and 2A).
LPS and IFN-
present for 20 h enhanced nitrite production in a
concentration-dependent manner from about 1 to 2 to maximally about 50 to 60 nmol/106 cells/20 h at 1 µg/ml LPS (Figs.
1 and 2A) or 500 U/ml IFN-
(data not shown; Fig. 2A). When cells
were treated with maximally effective concentrations of LPS or IFN-
for various time periods, nitrite accumulation was already
significantly elevated after 5 h and increased continuously up to
20 h (Fig. 2A).
|
|
|
resulted also in an increase of
L-[3H]arginine uptake
from about 3 to 5 to maximally 10 to 15 pmol/mg of protein. Both the
concentration dependence (shown only for LPS, Fig. 1) as well as the
time course (Fig. 2B) of this effect were identical with the changes
observed for nitrite accumulation.
As shown by RT-PCRs (Fig. 3), iNOS was
not detected in freshly prepared AM
, but was slightly induced by the
culture procedure alone. However, presence of LPS caused a rapid and
persistent increase in iNOS mRNA, an effect seen already after 2 h
and maximally expressed after 5 h. In freshly prepared AM
, mRNA
for two cationic amino acid transporters, CAT-1 and CAT-2B, was
detected. However, LPS caused a marked up-regulation of CAT-2B mRNA
without significant effects on CAT-1 mRNA (Figs. 3 and 7; Table 1). The
time course of up-regulation of CAT-2B mRNA paralleled that of iNOS
mRNA (Fig. 3). When maximally effective concentrations of LPS
and IFN-
were present together for 20 h, their stimulatory
effects on nitrite accumulation, L-arginine uptake, and
mRNA expression of iNOS and CAT-2B were not additive (Fig.
4).
|
|
Effect of NF-
B Inhibitors on LPS- and IFN-
-Induced NO
Production, L-Arginine Uptake, and mRNA Expression.
TLCK and PDTC, which had been shown to inhibit iNOS induction by
neutralizing the NF-
B signal transduction pathway in many cells,
caused similar effects in AM
. In a concentration-dependent manner
both inhibitors decreased nitrite accumulation by about 60% when
present alone and abrogated the LPS-induced up-regulation of NO
production with the maximal effects seen at 100 µM TLCK and 60 µM
PDTC for both basal and stimulated nitrite accumulation (Fig.
5A; data not shown). The IFN-
-induced
increase in nitrite accumulation was also prevented by 60 µM PDTC and
largely inhibited by 100 µM TLCK (Fig.
6A).
|
|
was also prevented by PDTC and
largely attenuated by TLCK (Fig. 6B).
In parallel, the influence of the NF-
B inhibitors on the mRNA
expression of iNOS, CAT-2B, and CAT-1 was studied. Because the maximal
induction of iNOS and CAT-2B mRNA was seen after 5-h exposure to LPS or
IFN-
, this time protocol was used to test the effects of the
NF-
B inhibitors. In these experiments LPS and IFN-
caused a
significant increase of the mRNA of iNOS and CAT-2B in the absence, but
not in the presence of either PDTC or TLCK (Fig.
7; Table 1). The mRNA expression of the
CAT-1 transporter was not significantly affected by any of these
treatments (Fig. 7; Table 1). However, prolonged exposure (20 h) to the
NF-
B inhibitors TLCK and PDTC caused a clear reduction in CAT-1 mRNA (data not shown).
|
Inhibition of NF-
B Signal Transduction Pathway by Decoy
Approach.
To confirm the involvement of NF-
B in the parallel
induction of iNOS and CAT-2B, the decoy ODN technique was applied. Best results were obtained when the AM
were preincubated with 10 µM ODNs for 4 to 24 h and when 10 µM ODNs were additionally present during the incubation with the LPS stimulus. When present 4 h before LPS, the NF-
B decoy ODN reduced significantly the induction of iNOS and CAT-2B mRNA, whereas the mutated decoy ODN had no significant effect (Fig. 8; Table
2). After 24-h preincubation with the
NF-
B decoy ODN (Table 2) the LPS-induced up-regulation of iNOS and
CAT-2B mRNA expression was completely inhibited. However, 24-h
preincubation with the mutated ODN caused also a significant reduction
of the induced iNOS and CAT-2B mRNA, although the magnitude of this
effect was substantially smaller than that of the NF-
B decoy ODN
(Table 2). The prolonged exposure to the NF-
B decoy ODN resulted
also in a significant reduction of the CAT-1 mRNA expression (Table 2),
an observation that is in line with the above-mentioned effect caused
by prolonged exposure to PDTC or TLCK. The long-term exposure to the
mutated decoy ODN tended also to reduce the CAT-1 mRNA, but the
NF-
B-specific decoy ODN caused a much larger and clearly significant
effect (Table 2).
|
|
Effect of Cycloheximide on iNOS and CAT-2B mRNA Expression.
Cycloheximide (10 µM), present 30 min prior and during the 5-h LPS
stimulation prevented the induction of iNOS mRNA as well as the
up-regulation of CAT-2B mRNA (Fig. 9).
The ratios of the absorbance of the PCR bands iNOS/respective
-actin
expressed as percentage of the respective LPS value were 3 ± 4, 4 ± 2, and 3 ± 1% for controls, cycloheximide alone, and
cycloheximide plus LPS, respectively. The respective values for CAT-2B
were 42 ± 14, 39 ± 16, and 46 ± 12% (each
n = 3, except for cycloheximide alone,
n = 2). The expression of CAT-1 mRNA was not affected
by cycloheximide, neither in the absence nor presence of LPS (data not
shown).
|
Short- and Long-Term Effect of Dexamethasone on iNOS and CAT-2B
Induction.
Because glucocorticoids have also been shown to
modulate iNOS expression, the effect of dexamethasone on nitrite
accumulation, L-arginine uptake (Table
3), and the expression of mRNA for iNOS and the CATs (Figs. 7 and 10) in AM
was additionally studied. Presence of dexamethasone (0.1-10 µM)
together with LPS during the 20-h culture period caused only a minor
reduction of the induced nitrite accumulation (data not shown). Because
nitrite determined in the medium of the 20-h culture period reflects NO
synthesis over the whole culture period, additional experiments were
performed to obtain information about the iNOS activity at the end of
the 20-h culture period. For this, AM
were incubated for additional 6 h in Krebs-HEPES solution containing 100 µM
L-arginine and the accumulation of nitrite was determined.
As summarized in Table 3, AM
that had been cultured in the presence
of LPS produced about 17 times more nitrite than control AM
.
Additional presence of dexamethasone (0.1 and 1 µM) during the
culture period resulted in a reduction of the LPS-induced NO synthesis
by 45 and 55%, respectively. At the higher concentration of 10 µM,
dexamethasone did not produce stronger inhibition (data not shown).
Dexamethasone also reduced the basal nitrite accumulation, maximally by
28% (Table 3). The glucocorticoid receptor antagonist mifepristone (1 µM) prevented the effect of 0.1 µM dexamethasone and largely reduced that of 1 µM dexamethasone (Table 3).
|
|
B inhibitors, dexamethasone (up to 10 µM)
did not affect the early LPS-induced increase in iNOS and CAT-2B mRNA
(seen after 5 h, Fig. 7), but down-regulated the LPS-induced iNOS
and CAT-2B mRNA expression after prolonged (20 h) exposure (Fig. 10)
and tended to reduce the basal levels of these mRNAs. After 20-h
culture, the ratios of the absorbance of the PCR bands iNOS × 100/respective
-actin were 5.5 ± 2.6 (n = 11)
for controls, 0.5 ± 0.3 (n = 6) for dexamethasone
alone (P < .05 versus controls), 69.9 ± 10.6 (n = 8) for LPS alone (P < .001 versus
controls), and 1.6 ± 1.0 (n = 3) for LPS plus
dexamethasone (P < .001 versus LPS alone). The
respective values for CAT-2B were 14.5 ± 4.4 (n = 11) for controls, 5.0 ± 1.6 (n = 6) for
dexamethasone alone (P < .05 versus controls),
96.8 ± 12.5 (n = 8) for LPS alone
(P < .001 versus controls), and 32.9 ± 11.3 (n = 3) for LPS plus dexamethasone (P < .01 versus LPS alone). Again, the expression of CAT-1 remained
unaffected for all tested time periods and concentrations of
dexamethasone (Fig. 7; Table 1; data not shown).
| |
Discussion |
|---|
|
|
|---|
In confirmation of previous observations on different types of
M
(Bogle et al., 1992
; Hammermann et al., 1999
) the present results
demonstrated that induction of iNOS in rat AM
by LPS or IFN-
is
accompanied by an activation of L-arginine transport. Moreover, both the LPS- and IFN-
-mediated induction of NO synthesis and the activation of L-arginine transport occurred in the
same time- and concentration-dependent manner (Figs. 1 and 2),
suggesting already that induction of iNOS and up-regulation of
L-arginine transport might be mediated by the same signal
transduction pathways.
As outlined in the Introduction, there is evidence that most of the
cellular uptake of L-arginine in rat AM
, particularly in
LPS-stimulated cells, is mediated via specific, high-affinity CATs
(Messeri Drei
ig et al., 2000
). Of the five known members of the CAT
family CAT-1 and CAT-2B have been shown to be expressed in rat AM
,
but only the expression of CAT-2B was enhanced after exposure to LPS or
IFN-
(Table 1), suggesting that an increased availability of the
CAT-2B transporter may be responsible for the enhanced
L-arginine uptake. Similar observations have been made in
different murine M
cell lines (Closs et al., 1993
; Kakuda et al.,
1999
). Moreover, the up-regulation of CAT-2B mRNA occurred simultaneously with the iNOS mRNA induction (Fig. 3), giving further support to the idea of a parallel regulation of iNOS expression and
L-arginine transport.
Because NF-
B is an essential transcription factor for the induction
of iNOS in M
(see Introduction), this transcription factor appeared
to be a likely candidate also for the regulation of CAT-2B expression.
Although at present the promoter region of the rat CAT-2 gene is not
yet known, we could identify two NF-
B sites in the partially
clarified mouse CAT-2 gene promoter (Finley et al., 1995
) using the
program MatInspector version 2.2 (Quandt et al., 1995
). The present
experiments applying three different strategies to inhibit
NF-
B-induced gene transcription indicate that indeed NF-
B is not
only involved in the regulation of NO synthesis by inducing the
expression of iNOS but also in the regulation of L-arginine
transport by controlling the expression of CAT-2B. PDTC and TLCK, which
inhibit NF-
B activation by acting at different sites in the NF-
B
signaling pathway (Sherman et al., 1993
; Kim et al., 1995
),
concomitantly abrogated LPS- and IFN-
-induced NO synthesis and iNOS
expression on one side and the up-regulation of L-arginine
transport and CAT-2B expression on the other side (Figs. 5-7; Table
1). Because the specificity of PDTC as antioxidant and TLCK as serine
protease inhibitor with regard to NF-
B inhibition might be
questionable, we finally used the transcription factor decoy approach
to demonstrate unequivocally the involvement of NF-
B in the
regulation of CAT-2B expression. ODN decoy approaches have been applied
successfully to inhibit transcriptional activation of different genes
in different cell types, including NF-
B-activated genes in M
(von
Knethen et al., 1999
). Treatment of rat AM
with the NF-
B
decoy ODN, of which the susceptibility to nuclease degradation had been
reduced by introducing phosphorothioate nucleotides, caused a parallel
attenuation of the LPS- and IFN-
-induced increase of iNOS and CAT-2B
mRNA (Fig. 8; Table 2). The specificity of the effect of the NF-
B decoy ODN was demonstrated by parallel experiments with an ODN in which
the NF-
B consensus sequences had been mutated. When the AM
were
preincubated with the ODNs 4 h before the LPS stimulus, the
NF-
B decoy ODN caused a clear reduction of both the induced mRNA of
iNOS and CAT-2B, whereas the mutated ODN had no significant effect.
When the ODNs were present already 24 h before the LPS stimulus,
the induction of iNOS mRNA and the up-regulation of CAT-2B mRNA were
prevented by the NF-
B decoy ODN. However, under these conditions,
the mutated ODN caused also a significant, although substantially
smaller, reduction of the induced iNOS and CAT-2B mRNA (Table 2).
Whether this is the result of weak interactions with NF-
B or caused
by unspecific effects, possibly due to the phosphorothioate
nucleotides, remains unclear. Nevertheless, the marked effects of the
NF-
B-specific decoy ODN together with those of TLCK and PDTC
strongly support the conclusion that NF-
B is an essential
transcription factor not only for induction of iNOS but also for the
up-regulation of CAT-2B. Interestingly, prolonged inhibition of the
NF-
B pathway, by either TLCK, PDTC, or the NF-
B decoy ODN
resulted also in a clear reduction of the CAT-1 mRNA, suggesting that
the expression of CAT-1 may in part be driven by a background activity
of NF-
B.
It had been shown that NF-
B is an essential, but alone not
sufficient transcription factor for the induction of iNOS in murine M
cell lines (Xie et al., 1994
, Ding et al., 1995
) and the same is
true for the activation of the iNOS and CAT-2 genes in rat AM
. The
observation that cycloheximide prevented the up-regulation of iNOS and
CAT-2B mRNA indicates that in addition to NF-
B that is present in
the cytosol as inactive complex with different isoforms of inhibitor of
NF-
B (Baeuerle, 1998
), newly synthesized proteins contribute to the
activation of the respective promoters. The nature of such proteins
remains unknown at present.
Finally, a closely parallel modulation of iNOS expression and NO
synthesis on one side and CAT-2B expression and L-arginine transport on the other side was also observed for glucocorticoids. Dexamethasone did not affect the initial up-regulation of iNOS and
CAT-2B mRNA (Fig. 7; Table 1), but caused a down-regulation of both
mRNAs after prolonged exposure (Fig. 10). After 20-h exposure to
dexamethasone the LPS effect on iNOS mRNA was abolished and that on
CAT-2B mRNA largely attenuated. The magnitude of the effect of
dexamethasone on mRNA levels appeared to be larger than that on the
functional responses, particularly for the inhibition of iNOS mRNA and
the reduction of stimulated NO synthesis. This apparent discrepancy can
be explained by a delayed decline of iNOS protein after the
down-regulation of the de novo synthesis. The inhibitory effects of
dexamethasone on NO synthesis and L-arginine transport were
antagonized by the glucocorticoid receptor antagonist mifepristone (Cadepond et al., 1997
), indicating a nuclear site of action via the
glucocorticoid-receptor complex. However, the delay in onset of the
effects of dexamethasone argues against a direct suppressive action at
the promoter region of the iNOS and CAT-2 gene. An indirect modulation
via the induction of inhibitory trans-acting factors such as
lipocortin-1 (Flower and Rothwell, 1994
), inhibitor of
B (Scheinman
et al., 1995
), or E4BP4 (Wallace et al., 1997
) appears to be more
likely. However, this has not been illuminated in the present study. It
should be mentioned that experiments with antibodies against
lipocortin-1 indicated that this glucocorticoid-induced protein may at
least in part mediate the inhibitory effects of glucocorticoids on iNOS
induction in murine M
(Wu et al., 1995
). The indirect way of action
of glucocorticoids may also explain some of the cell-specific
differences in their effects. Thus, in murine J774 M
(Baydoun et
al., 1993
) and astrocytes (Schmidlin and Wiesinger, 1995
)
glucocorticoids inhibited LPS-mediated iNOS induction, but not
LPS-induced up-regulation of L-arginine
transport. However, cell type-specific differences in the regulation of
the expression of CATs appear also possible, because it was very
recently shown that in J774 M
the LPS-induced up-regulation of
CAT-2B and iNOS mRNA occurred with different kinetics (Closs et al., 2000
), in contrast to the present observations on rat AM
.
In conclusion, the present findings demonstrated a parallel regulation
of the expression of iNOS and CAT-2B, and of NO synthesis and
L-arginine uptake in rat AM
. NF-
B was shown to be an
essential, but alone not sufficient transcription factor for both the
induction of iNOS and the up-regulation of CAT-2B. The simultaneous
up-regulation of CAT-2B with iNOS is considered as a mechanism to
ensure a high substrate supply for iNOS. A functionally close link
between CAT-2B-mediated L-arginine transport and
iNOS-mediated NO synthesis has recently been demonstrated in M
of mice in which the CAT-2 gene was ablated (MacLeod et al., 1999
),
because in M
from CAT-2 knockout mice the induction of iNOS did not
result in an increased NO synthesis.
| |
Footnotes |
|---|
Received March 23, 2000; Accepted September 7, 2000
1 Current address: Institute of Pharmacology and Toxicology, II University of Naples, Naples, Italy.
This work was supported by Deutsche Forschungsgemeinschaft (Ra 400/9-1 and 9-2). M.D.M.D. and L.B. were supported by travel grants of the "Vigoni Programm" of the Deutsche Akademische Auslandsdienst and the Conferenza Permanente dei Rettori delle Università Italiane, respectively.
Send reprint requests to: Dr. Rainer Hammermann, Institute of Pharmacology and Toxicology, University of Bonn, Reuterstr. 2b, D-53113 Bonn, Germany. E-mail: r.hammermann{at}uni-bonn.de
| |
Abbreviations |
|---|
M
, macrophages;
NO, nitric oxide;
NOS, nitric-oxide synthase;
iNOS, inducible nitric-oxide synthase;
AM
, alveolar macrophages;
LPS, lipopolysaccharide;
IFN-
, interferon-
;
NF-
B, nuclear factor-
B;
CAT, cationic amino acid transporter;
ODN, oligodesoxynucleotide;
PDTC, pyrrolidine dithiocarbamate;
TLCK, N
-p-tosyl-L-lysine
chloromethyl ketone;
RT, reverse transcription;
PCR, polymerase chain
reaction;
bp, base pair.
| |
References |
|---|
|
|
|---|
B-NF-
B structures: At the interface of inflammation control.
Cell
95:
729-731[Medline].
-hydroxy-D, L-indospicine, effects on L-arginine utilization by nitric oxide synthase.
Br J Pharmacol
121:
395-400[Medline].
B.
J Immunol
154:
4741-4748[Abstract].
B site is required for the maximal expression of mouse inducible nitric oxide synthase gene in interferon-
plus lipopolysaccharide-induced RAW 264.7 macrophages.
Biochem Biophys Res Commun
236:
655-660[Medline].
and lipopolysaccharide.
Proc Natl Acad Sci USA
90:
9730-9734
ig MD,
Hammermann R,
Mössner J,
Göthert M and
Racké K
(2000)
In rat alveolar macrophages lipopolysaccharides exert diverge effects on the transport of the cationic amino acids L-arginine and L-ornithine.
Naunyn-Schmiedeberg's Arch Pharmacol
361:
621-628[Medline].
B
in mediation of immunosuppression by glucocorticoids.
Science (Wash DC)
270:
283-286
B and AP-1 activation by nitric oxide attenuated apoptotic cell death in RAW 264.7 macrophages.
Mol Biol Cell
10:
361-372
B/Rel in induction of nitric oxide synthase.
J Biol Chem
269:
4705-4708
.
J Leukocyte Biol
59:
575-585[Abstract].
This article has been cited by other articles:
![]() |
M. Cattaruzza, K. Schafer, and M. Hecker Cytokine-induced Down-regulation of zfm1/Splicing Factor-1 Promotes Smooth Muscle Cell Proliferation J. Biol. Chem., February 15, 2002; 277(8): 6582 - 6589. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Sala, B. M. Rotoli, E. Colla, R. Visigalli, A. Parolari, O. Bussolati, G. C. Gazzola, and V. Dall'Asta Two-way arginine transport in human endothelial cells: TNF-alpha stimulation is restricted to system y+ Am J Physiol Cell Physiol, January 1, 2002; 282(1): C134 - C143. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Kiemer and A. M. Vollmar Induction of L-Arginine Transport Is Inhibited by Atrial Natriuretic Peptide: A Peptide Hormone as a Novel Regulator of Inducible Nitric-Oxide Synthase Substrate Availability Mol. Pharmacol., September 1, 2001; 60(3): 421 - 426. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||